These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25809834)

  • 21. Full recovered meningoencephalomyelitis caused by mumps virus.
    Savaş L; Arlier Z; Akçali A; Karataş M; Onlen Y
    Eur J Neurol; 2004 Sep; 11(9):639-40. PubMed ID: 15379744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Encephalitis, meningitis serosa and parotitis after MMR preventive vaccination? The Pediatric Vaccination Counseling Unit].
    Wiersbitzky S; Bruns R; Peters A; Mentel R
    Kinderarztl Prax; 1992 Oct; 60(7):203-5. PubMed ID: 1359186
    [No Abstract]   [Full Text] [Related]  

  • 23. Protracted mumps encephalitis with good outcome.
    Kim P; Cappelen-Smith C
    J Clin Neurosci; 2005 Nov; 12(8):959-61. PubMed ID: 16257214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
    Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Akinetic mutism induced by tacrolimus.
    Sierra-Hidalgo F; Martínez-Salio A; Moreno-García S; de Pablo-Fernández E; Correas-Callero E; Ruiz-Morales J
    Clin Neuropharmacol; 2009; 32(5):293-4. PubMed ID: 19820432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R; Svensson E; Trollfors B; Borres MP
    Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation].
    Zverev VV; Iuminova NV
    Vopr Virusol; 2004; 49(3):8-11. PubMed ID: 15188648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-reported histories of disease and vaccination against measles, mumps, rubella and varicella in health care personnel in Japan.
    Kumakura S; Onoda K; Hirose M
    J Infect Chemother; 2014 Mar; 20(3):194-8. PubMed ID: 24462433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severity of mumps disease is related to MMR vaccination status and viral shedding.
    Gouma S; Hahné SJ; Gijselaar DB; Koopmans MP; van Binnendijk RS
    Vaccine; 2016 Apr; 34(16):1868-73. PubMed ID: 26954106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Central nervous system infection caused by mumps virus].
    Saijo M; Fujita K
    Nihon Rinsho; 1997 Apr; 55(4):870-5. PubMed ID: 9103886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
    Krober MS; Stracener CE; Bass JW
    JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine.
    LeBaron CW; Bi D; Sullivan BJ; Beck C; Gargiullo P
    Pediatrics; 2006 Oct; 118(4):1422-30. PubMed ID: 17015532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.
    Yadav S; Thukral R; Chakarvarti A
    Indian J Med Res; 2003 Nov; 118():183-6. PubMed ID: 14723482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.